한글목차

의약품 API 제조 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 2,506억 6,000만 달러에서 2026년에는 2,667억 2,000만 달러에 이르고, CAGR 6.4%로 성장할 전망입니다. 지난 몇 년간의 성장 요인으로는 첨단 의약품 API 제조 시설공급 부족, 기존 일괄 처리 방식에 대한 의존도, 의약품 파이프라인의 확대, 만성질환 및 생활습관병 증가, 표준 품질관리 시스템 도입 등을 들 수 있습니다.

의약품 API 제조 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 3,474억 9,000만 달러에 이르고, CAGR은 6.8%를 나타낼 전망입니다. 예측 기간 동안의 성장은 바이오의약품 및 복잡한 분자의 개발, 연속 생산 공정의 확대, 특수 API에 대한 R&D 투자 증가, 맞춤형 및 표적 치료제에 대한 수요 증가, 규제 요건 강화 및 컴플라이언스 모니터링 강화에 기인할 것으로 예측됩니다. 예측 기간 동안 주요 동향으로는 고순도 화학 및 생물학적 원료의약품에 대한 수요 증가, 위탁생산 및 아웃소싱 서비스의 성장, 품질 관리 및 규제 준수에 대한 관심 증가, 표적 치료제를 위한 특수 원료의약품의 확대, 연속 생산 및 공정 최적화 기술의 채택 등이 있습니다.

만성질환 증가 추세는 향후 의약품 API 제조 시장의 확대를 촉진할 것으로 예측됩니다. 만성질환은 장기간 지속되고, 종종 평생 동안 치유하기 어려운 건강 문제입니다. 의약품의 품질, 유효성, 안전성은 사용되는 원약에 따라 크게 좌우됩니다. 의약품 API 제조는 만성질환의 지속적인 관리에 필수적인 의약품을 생산하고 있습니다. 예를 들어, 2023년 1월 미국 질병예방통제센터(CDC)가 발표한 자료에 따르면, 2023년 기준 미국 성인의 76.4%(약 1억 9,400만 명)가 적어도 한 가지 이상의 만성질환을 앓고 있으며, 젊은 성인의 유병률은 59.5%, 중장년층은 78.4%, 노년층은 93.0%에 달하고 있습니다. 도달하고 있습니다. 따라서 만성질환 증가가 의약품 API 제조 시장을 주도하고 있습니다.

의약품 API 제조 시장의 주요 기업들은 생산 효율성 향상, 규제 대응, 제품 기준 향상을 위해 의약품 API 제조 플랜트 등 선진화된 시설을 추진하고 있습니다. 원료의약품(API : Active Pharmaceutical Ingredient) 제조공장이란 의약품의 핵심이 되는 생물학적 활성 성분을 생산하기 위한 전용 시설입니다. 예를 들어, 2023년 11월 인도 제약회사 카디라 파마(Kadira Pharma)는 최첨단 원료의약품(API) 생산 공장을 개소했습니다. 이 첨단 설비에는 분산 제어 시스템(DCS) 자동화가 내장되어 있어 생산 속도를 높이고 최고 수준의 API 순도를 보장합니다. 이러한 성장은 고품질 의약품에 대한 세계 수요 증가에 대응하고, 현지 고용을 창출하며, 치료 분야 전반의 혁신을 촉진하기 위한 카디라의 노력을 강조하는 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Pharmaceutical active pharmaceutical ingredients (API) manufacturing involves producing the active substances in medicines that provide their therapeutic effect to treat specific conditions. This process requires the chemical processing of components, while in biological drugs, the active ingredient is referred to as a bulk process intermediate.

The main therapy areas for pharmaceutical API manufacturing include cardiovascular disorders, metabolic disorders, neurological disorders, oncology, musculoskeletal disorders, NSAIDs, and other therapeutic applications. Cardiovascular disorders encompass a range of heart and blood vessel diseases. The APIs are categorized into chemical APIs and biological APIs, which are used to produce innovative drugs, generic prescription medicines, and over-the-counter (OTC) products.

Tariffs have impacted the pharmaceutical API manufacturing market by increasing the cost of imported raw materials, intermediates, and bioreactors, affecting both chemical and biological API production. Segments like specialty APIs and high-purity biologics are most affected, with Asia-Pacific regions including China and India, as major suppliers, facing the highest duties. This has led to increased production costs and potential supply chain delays. On the positive side, tariffs have encouraged domestic manufacturing, investment in local R&D, and development of cost-efficient production technologies.

The pharmaceutical api manufacturing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical api manufacturing market statistics, including pharmaceutical api manufacturing industry global market size, regional shares, competitors with a pharmaceutical api manufacturing market share, detailed pharmaceutical api manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical api manufacturing industry. This pharmaceutical api manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical api manufacturing market size has grown strongly in recent years. It will grow from $250.66 billion in 2025 to $266.72 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to limited availability of advanced api manufacturing facilities, reliance on traditional batch processing, growing pharmaceutical product pipelines, increasing prevalence of chronic and lifestyle disorders, adoption of standard quality management systems.

The pharmaceutical api manufacturing market size is expected to see strong growth in the next few years. It will grow to $347.49 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to development of biologics and complex molecules, expansion of continuous manufacturing processes, increasing investment in r&d for specialty apis, rising demand for personalized and targeted therapeutics, growing regulatory requirements and compliance monitoring. Major trends in the forecast period include rising demand for high-purity chemical and biological apis, growth in contract manufacturing and outsourcing services, increasing focus on quality control and regulatory compliance, expansion of specialty apis for targeted therapeutics, adoption of continuous manufacturing and process optimization techniques.

The uptick in chronic conditions is anticipated to boost the pharmaceutical API manufacturing market ahead. Chronic conditions, or chronic diseases, are enduring health issues that persist over long durations, often lifelong, and generally resist full cures. Medication quality, potency, and safety hinge heavily on the API employed. Pharmaceutical API manufacturing crafts vital drugs for ongoing chronic disease control. For instance, in January 2023, the Centers for Disease Control and Prevention (CDC), a US-based federal agency, noted 76.4% of U.S. adults-about 194 million-reported at least one chronic condition in 2023, with rates at 59.5% for young adults, 78.4% for midlife adults, and 93.0% for older adults. Therefore, the rise in chronic conditions is driving the pharmaceutical API manufacturing market.

Prominent companies in the pharmaceutical API manufacturing market are advancing novel facilities like API manufacturing plants to sharpen output efficiency, meet regulations, and elevate product standards. An API (Active Pharmaceutical Ingredient) manufacturing plant is a dedicated site for producing the core bioactive elements in drug formulations. For instance, in November 2023, Cadila Pharma, an India-based pharmaceutical company, opened a cutting-edge Active Pharmaceutical Ingredients (API) manufacturing plant. The advanced setup incorporates Distributed Control System (DCS) automation to boost production speed and guarantee top-tier API purity. This growth underscores Cadila's dedication to fulfilling rising worldwide needs for premium pharmaceuticals, generating local jobs, and advancing innovation across therapy fields.

In August 2023, Sigachi Industries Ltd., an India-based pharmaceutical company, acquired Trimax Biosciences for $12 million. Through this acquisition, Sigachi strategically aims to expand its operations into the Active Pharmaceutical Ingredients (API) sector, enhancing its capabilities in developing and supplying a diverse range of APIs to meet growing pharmaceutical demand and strengthening its competitive position in the healthcare industry. Trimax Biosciences is an India-based pharmaceutical company that specializes in the manufacturing of active pharmaceutical ingredients (APIs).

Major companies operating in the pharmaceutical api manufacturing market are Pfizer Inc, Sanofi S.A, Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Dr. Reddy's Laboratories, BASF SE, Sun Pharmaceutical Industries Ltd, Novartis AG, Lupin Ltd, Cipla Inc., Arlak Biotech, Healthkind Labs Pvt. Ltd, SwisscheM Healthcare Pvt. Ltd, Apikos Pharma, Kolaz Biotech, CStone Pharma, CARsgen Therapeutics, JW Therapeutics, BeiGene, Takeda Pharmaceuticals, Astellas Pharma Inc, Otsuka Pharmaceutical Co Ltd, Legend Biotech Co, Zai Lab, Daiichi Pharmaceutical, Sankyo, GlaxoSmithKline (GSK), AstraZeneca, Abbott Laboratories, Roche Holding AG, Merck & Co, Boehringer Ingelheim, Zentiva, Microgen, Geropharm, Valenta, NovaMedica, Veropharm, Celon Pharma, SynBio, Generium, Skopinpharm, ALMEDIS, Biocad, Farmacol, Polpharma, BioVectra, Celgene Corporation, Kashiv Pharma, Cambrex, Eli Lilly and Company, Bristol-Myers Squibb Company, Apotex, Gilead Sciences, AbbVie Inc, Hisun USA Inc, AMEGA Biotech, BioMarin Pharmaceutical, Ferring Pharmaceuticals, Wavelength Pharmaceuticals, SAUDIBIO, Tabuk Pharmaceuticals, Bayer, Adcock Ingram, Johnson & Johnson, Aspen

North America was the largest region in the pharmaceutical API manufacturing market in 2025. The Middle East is expected to be the fastest-growing region in the global pharmaceutical API manufacturing market share during the forecast period. The regions covered in the pharmaceutical api manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical api manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical active pharmaceutical ingredients (API) manufacturing market includes tablets, capsules, creams, and injectable sales. Values in this market are factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical API Manufacturing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pharmaceutical api manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical api manufacturing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical api manufacturing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Therapy Area: Cardiovascular Disorders; Metabolic Disorders; Neurological Disorders; Oncology; Musculoskeletal Disorders; Other Therapeutic Uses
• 2) By API Type: Chemical API; Biological API
• 3) By Drug Type: Prescription Drugs; Over-The-Counter (OTC) Drugs
• Subsegments:
• 1) By Cardiovascular Disorders: Hypertension Treatments; Cholesterol Management; Anticoagulants
• 2) By Metabolic Disorders: Diabetes Medications; Obesity Management; Hormonal Therapies
• 3) By Neurological Disorders: Antiepileptics; Antidepressants; Neurodegenerative Disease Treatments
• 4) By Oncology: Chemotherapeutics; Targeted Therapies; Immunotherapies
• 5) By Musculoskeletal Disorders: Pain Management Medications; Osteoporosis Treatments; Anti-inflammatory Drugs
• 6) By Other Therapeutic Uses: Infectious Disease Treatments; Respiratory Disorder Medications; Gastrointestinal Disorder Treatments
• Companies Mentioned: Pfizer Inc; Sanofi S.A; Teva Pharmaceutical Industries Ltd.; Aurobindo Pharma; Dr. Reddy's Laboratories; BASF SE; Sun Pharmaceutical Industries Ltd; Novartis AG; Lupin Ltd; Cipla Inc.; Arlak Biotech; Healthkind Labs Pvt. Ltd; SwisscheM Healthcare Pvt. Ltd; Apikos Pharma; Kolaz Biotech; CStone Pharma; CARsgen Therapeutics; JW Therapeutics; BeiGene; Takeda Pharmaceuticals; Astellas Pharma Inc; Otsuka Pharmaceutical Co Ltd; Legend Biotech Co; Zai Lab; Daiichi Pharmaceutical; Sankyo; GlaxoSmithKline (GSK); AstraZeneca; Abbott Laboratories; Roche Holding AG; Merck & Co; Boehringer Ingelheim; Zentiva; Microgen; Geropharm; Valenta; NovaMedica; Veropharm; Celon Pharma; SynBio; Generium; Skopinpharm; ALMEDIS; Biocad; Farmacol; Polpharma; BioVectra; Celgene Corporation; Kashiv Pharma; Cambrex; Eli Lilly and Company; Bristol-Myers Squibb Company; Apotex; Gilead Sciences; AbbVie Inc; Hisun USA Inc; AMEGA Biotech; BioMarin Pharmaceutical; Ferring Pharmaceuticals; Wavelength Pharmaceuticals; SAUDIBIO; Tabuk Pharmaceuticals; Bayer; Adcock Ingram; Johnson & Johnson; Aspen
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Pharmaceutical API Manufacturing Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Pharmaceutical API Manufacturing Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Pharmaceutical API Manufacturing Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Pharmaceutical API Manufacturing Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Rising Demand For High-Purity Chemical And Biological Apis
  • 4.2.2 Growth In Contract Manufacturing And Outsourcing Services
  • 4.2.3 Increasing Focus On Quality Control And Regulatory Compliance
  • 4.2.4 Expansion Of Specialty Apis For Targeted Therapeutics
  • 4.2.5 Adoption Of Continuous Manufacturing And Process Optimization Techniques

5. Pharmaceutical API Manufacturing Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Companies
• 5.2 Biotechnology Firms
• 5.3 Contract Manufacturing Organizations (Cmos)
• 5.4 Hospitals And Clinics
• 5.5 Research & Academic Institutions

6. Pharmaceutical API Manufacturing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharmaceutical API Manufacturing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Pharmaceutical API Manufacturing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Pharmaceutical API Manufacturing Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Pharmaceutical API Manufacturing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Pharmaceutical API Manufacturing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharmaceutical API Manufacturing Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharmaceutical API Manufacturing Market Segmentation

• 9.1. Global Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Musculoskeletal Disorders, Other Therapeutics Uses
• 9.2. Global Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Chemical API, Biological API
• 9.3. Global Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Prescription Drugs, Over-The-Counter (OTC) Drugs
• 9.4. Global Pharmaceutical API Manufacturing Market, Sub-Segmentation Of Cardiovascular Disorders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hypertension Treatments, Cholesterol Management, Anticoagulants
• 9.5. Global Pharmaceutical API Manufacturing Market, Sub-Segmentation Of Metabolic Disorders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diabetes Medications, Obesity Management, Hormonal Therapies
• 9.6. Global Pharmaceutical API Manufacturing Market, Sub-Segmentation Of Neurological Disorders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Antiepileptics, Antidepressants, Neurodegenerative Disease Treatments
• 9.7. Global Pharmaceutical API Manufacturing Market, Sub-Segmentation Of Oncology, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Chemotherapeutics, Targeted Therapies, Immunotherapies
• 9.8. Global Pharmaceutical API Manufacturing Market, Sub-Segmentation Of Musculoskeletal Disorders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pain Management Medications, Osteoporosis Treatments, Anti-inflammatory Drugs
• 9.9. Global Pharmaceutical API Manufacturing Market, Sub-Segmentation Of Other Therapeutic Uses, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Infectious Disease Treatments, Respiratory Disorder Medications, Gastrointestinal Disorder Treatments

10. Pharmaceutical API Manufacturing Market Regional And Country Analysis

• 10.1. Global Pharmaceutical API Manufacturing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Pharmaceutical API Manufacturing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharmaceutical API Manufacturing Market

• 11.1. Asia-Pacific Pharmaceutical API Manufacturing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharmaceutical API Manufacturing Market

• 12.1. China Pharmaceutical API Manufacturing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharmaceutical API Manufacturing Market

• 13.1. India Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharmaceutical API Manufacturing Market

• 14.1. Japan Pharmaceutical API Manufacturing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharmaceutical API Manufacturing Market

• 15.1. Australia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharmaceutical API Manufacturing Market

• 16.1. Indonesia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharmaceutical API Manufacturing Market

• 17.1. South Korea Pharmaceutical API Manufacturing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharmaceutical API Manufacturing Market

• 18.1. Taiwan Pharmaceutical API Manufacturing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharmaceutical API Manufacturing Market

• 19.1. South East Asia Pharmaceutical API Manufacturing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharmaceutical API Manufacturing Market

• 20.1. Western Europe Pharmaceutical API Manufacturing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharmaceutical API Manufacturing Market

• 21.1. UK Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharmaceutical API Manufacturing Market

• 22.1. Germany Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharmaceutical API Manufacturing Market

• 23.1. France Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharmaceutical API Manufacturing Market

• 24.1. Italy Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharmaceutical API Manufacturing Market

• 25.1. Spain Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharmaceutical API Manufacturing Market

• 26.1. Eastern Europe Pharmaceutical API Manufacturing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharmaceutical API Manufacturing Market

• 27.1. Russia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharmaceutical API Manufacturing Market

• 28.1. North America Pharmaceutical API Manufacturing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharmaceutical API Manufacturing Market

• 29.1. USA Pharmaceutical API Manufacturing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharmaceutical API Manufacturing Market

• 30.1. Canada Pharmaceutical API Manufacturing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharmaceutical API Manufacturing Market

• 31.1. South America Pharmaceutical API Manufacturing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharmaceutical API Manufacturing Market

• 32.1. Brazil Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharmaceutical API Manufacturing Market

• 33.1. Middle East Pharmaceutical API Manufacturing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharmaceutical API Manufacturing Market

• 34.1. Africa Pharmaceutical API Manufacturing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Segmentation By API Type, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharmaceutical API Manufacturing Market Regulatory and Investment Landscape

36. Pharmaceutical API Manufacturing Market Competitive Landscape And Company Profiles

• 36.1. Pharmaceutical API Manufacturing Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Pharmaceutical API Manufacturing Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Pharmaceutical API Manufacturing Market Company Profiles
  • 36.3.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Sanofi S.A Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Aurobindo Pharma Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Dr. Reddy's Laboratories Overview, Products and Services, Strategy and Financial Analysis

37. Pharmaceutical API Manufacturing Market Other Major And Innovative Companies

• BASF SE, Sun Pharmaceutical Industries Ltd, Novartis AG, Lupin Ltd, Cipla Inc., Arlak Biotech, Healthkind Labs Pvt. Ltd, SwisscheM Healthcare Pvt. Ltd, Apikos Pharma, Kolaz Biotech, CStone Pharma, CARsgen Therapeutics, JW Therapeutics, BeiGene, Takeda Pharmaceuticals

38. Global Pharmaceutical API Manufacturing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pharmaceutical API Manufacturing Market

40. Pharmaceutical API Manufacturing Market High Potential Countries, Segments and Strategies

• 40.1 Pharmaceutical API Manufacturing Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Pharmaceutical API Manufacturing Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Pharmaceutical API Manufacturing Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer